Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Sales | 2,299,000 | 2,094,900 | 1,980,300 | 7,608,900 | 8,563,100 |
| Cost of Goods | 985,600 | 865,000 | 782,700 | 4,548,600 | 5,075,500 |
| Gross Profit | 1,313,400 | 1,229,900 | 1,197,600 | 3,060,300 | 3,487,600 |
| Operating Expenses | 928,400 | 773,700 | 799,200 | 2,915,300 | 2,111,800 |
| Operating Income | 385,600 | 456,200 | 399,100 | 145,600 | 1,376,300 |
| Interest Expense | 117,400 | 143,700 | 143,600 | 237,100 | 293,600 |
| Other Income | -108,800 | 33,200 | -7,500 | 279,900 | 37,500 |
| Pre-tax Income | 159,400 | 345,700 | 248,000 | 188,400 | 1,120,200 |
| Income Tax | 39,800 | 36,200 | 13,300 | 95,600 | 346,300 |
| Net Income Continuous | 119,600 | 309,500 | 234,700 | 92,800 | 773,900 |
| Net Income Discontinuous | 787,200 | 186,500 | 12,400 | 152,500 | 13,100 |
| Minority Interests | 4,100 | 8,400 | 4,300 | -65,800 | 24,400 |
| Net Income | $902,700 | $487,600 | $242,800 | $311,100 | $762,600 |
| EPS Basic Total Ops | 5.83 | 3.20 | 1.61 | 2.05 | 4.98 |
| EPS Basic Continuous Ops | 0.77 | 2.03 | 1.56 | 1.04 | 4.89 |
| EPS Basic Discontinuous Ops | 5.06 | 1.17 | 0.05 | 1.01 | 0.09 |
| EPS Diluted Total Ops | 5.72 | 3.16 | 1.60 | 2.02 | 4.87 |
| EPS Diluted Continuous Ops | 0.76 | 2.01 | 1.55 | 1.03 | 4.79 |
| EPS Diluted Discontinuous Ops | 4.96 | 1.15 | 0.05 | 0.99 | 0.08 |
| EBITDA(a) | $585,000 | $701,300 | $653,800 | $411,100 | $1,656,699 |